Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170011/S064

Impella RP Flex with SmartAssist

Abiomed, Inc. · Decision date Oct 26, 2026

MEDTECHLEDGER EXPLANATIONP170011/S064

What did the FDA decide?

The FDA record P170011/S064 is a 30-day notice for the Impella RP Flex with SmartAssist, listed as a temporary non-roller type right heart support blood pump under product code PYX, submitted by Abiomed, Inc. Its stated purpose is to add a supplier for the RP outflow cage. The listed reason is a process change covering manufacturer, sterilizer, packager or supplier.

The record does not identify the new supplier, describe the cage material or specifications, or state what verification supported the change. The identifier places it as supplement S064 to PMA P170011, so it concerns that approved device rather than an original approval or a new indication. The reported purpose is a manufacturing change, not independent evidence of safety or clinical effectiveness.

FDA approval order statement

to add a supplier for the RP outflow cage
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 26, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P170011/S064
Regulatory pathway
PMA supplement
Applicant
Abiomed, Inc.
Product code
PYX
Decision code
OK30
Decision date
Oct 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Temporary non-roller type right heart support blood pump.

Applicant
Abiomed, Inc.
Product code
PYX
FDA device class
3

For the original device and its historical approval scope, see PMA P170011. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P170011 · Original PMA

    Impella RP System

  2. P170011/S064 received

    Application receipt date recorded by FDA.

  3. P170011/S064 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P170011. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170011

Product / regulatory recordCompanyPathwayDecision dateSource
Abiomed, Inc.PMA approvalSep 20, 2017FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abiomed, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
22 Cherry Hill Dr., Danvers, MA, 01923

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records